In Brief This Week: Almac Diagnostics; Leica, Aperio; GenScript; University of Nebraska | GenomeWeb

NEW YORK (GenomeWeb News) – Almac Diagnostics said this week that it has launched a next-generation sequencing service to its portfolio, which also includes microarray, qPCR, and immunohistochemical offerings. Northern Ireland-based Almac said that the new NGS service will initially use the Illumina MiSeq platform.


Leica Biosystems has entered into a definitive agreement to acquire Aperio, expanding its digital pathology business. Terms of the acquisition were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.